ImportRefusal LogoImportRefusal

New Guyana Pharmaceutical Corp.

⚠️ Moderate Risk

FEI: 3003518730 • Georgetown • GUYANA

FEI

FEI Number

3003518730

📍

Location

Georgetown

🇬🇾

Country

GUYANA
🏢

Address

Al Farm, East Bank Demerarap.O.Box 10291, , Georgetown, , Guyana

Moderate Risk

FDA Import Risk Assessment

45.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
2
Unique Violations
11/26/2003
Latest Refusal
11/26/2003
Earliest Refusal

Score Breakdown

Violation Severity
78.6×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

755×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
11/26/2003
65CBN99NUTRIENT/TONIC N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/26/2003
54ACL07NICOTINAMIDE (NIACINAMIDE) (VITAMIN)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/26/2003
62FBY99ANTI-INFECTIVE, TOPICAL N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/26/2003
62FBY99ANTI-INFECTIVE, TOPICAL N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/26/2003
60CBN10PSEUDOEPHEDRINE HCL (ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is New Guyana Pharmaceutical Corp.'s FDA import refusal history?

New Guyana Pharmaceutical Corp. (FEI: 3003518730) has 5 FDA import refusal record(s) in our database, spanning from 11/26/2003 to 11/26/2003.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. New Guyana Pharmaceutical Corp.'s FEI number is 3003518730.

What types of violations has New Guyana Pharmaceutical Corp. received?

New Guyana Pharmaceutical Corp. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about New Guyana Pharmaceutical Corp. come from?

All FDA import refusal data for New Guyana Pharmaceutical Corp. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.